A transgenic vector was generated encoding the C-terminal hemagglutinin (HA)-tagged human LRRK2 gene with complete deletion of the kinase domain (deletion of residues 1187 to 2102) under control of a tetO promoter. The construct was microinjected into fertilized oocytes. Line D10 was analyzed further.